CMG Pharmaceutical Co., Ltd.

KOSDAQ 058820.KQ

CMG Pharmaceutical Co., Ltd. Capital Expenditure for the year ending December 31, 2023: USD -9.51 M

CMG Pharmaceutical Co., Ltd. Capital Expenditure is USD -9.51 M for the year ending December 31, 2023, a -80.87% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).

CMG Pharmaceutical Co., Ltd. Capital Expenditure for the year ending December 31, 2022 was USD -5.26 M, a -1,319.87% change year over year.
CMG Pharmaceutical Co., Ltd. Capital Expenditure for the year ending December 31, 2021 was USD -370.35 K, a -8.06% change year over year.
CMG Pharmaceutical Co., Ltd. Capital Expenditure for the year ending December 31, 2020 was USD -342.74 K, a 94.38% change year over year.
CMG Pharmaceutical Co., Ltd. Capital Expenditure for the year ending December 31, 2019 was USD -6.10 M.

Key data

Date	Capital Expenditure	Free Cash Flow	Depreciation And Amortization	Deferred Income Tax

KOSDAQ: 058820.KQ

CMG Pharmaceutical Co., Ltd.

CEO	Joohyung Lee
IPO Date	Nov. 19, 2001
Location	South Korea
Headquarters	Cheongdam-dong 18-20, #B01
Employees	272
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Composite Materials Dental Care Drugstores & Retail Pharmacies Eyewear Personal Care Plastics

Description

CMG Pharmaceutical Co., Ltd., a pharmaceutical company, develops and sells oral thin film (OTF) pharmaceuticals in South Korea. It offers Tadalafil OTF products for erectile dysfunction; Entecavir OTF products to treat hepatitis type B; Aripiprazole OTF products for schizophrenia; and Montelukast OTF products to treat asthma and allergic rhinitis. CMG Pharmaceutical Co. Ltd. has a strategic collaboration agreement with Handok Inc. for cancer treatment. The company was formerly known as Skynewpharm Co Ltd and changed its name to CMG Pharmaceutical CO., Ltd. in April 2013. CMG Pharmaceutical Co., Ltd. was founded in 2001 and is headquartered in Seoul, South Korea.

Key trends

Past 5 years